SCHEMBL6171908

SCHEMBL6171908

CC1(Cc2ccncc2NC(=O)NCc2ccccc2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 17/20 0.49
IGF1R P08069 1/20 0.41
CYP2C9 P11712 1/20 0.38
FPR2 P25090 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175985 0.89 IGF1R (0.41) NAMPTIGF1RCYP2C9
SCHEMBL6708303 0.87 TRPV1 (0.50) NAMPT
SCHEMBL6174148 0.87 IGF1R (0.40) NAMPTIGF1RCYP2C9
SCHEMBL6171771 0.87 IGF1R (0.41) IGF1R
SCHEMBL6173238 0.86 IGF1R (0.41) NAMPTIGF1R
SCHEMBL6174087 0.84 IGF1R (0.40) NAMPTIGF1RCYP2C9
SCHEMBL6174680 0.83 IGF1R (0.37) NAMPTIGF1RCYP2C9
SCHEMBL2938553 0.83 IGF1R (0.61) NAMPTIGF1RCYP2C9
SCHEMBL6171051 0.82 NAMPT (0.48) NAMPTCYP2C9
SCHEMBL6175557 0.82 GAA (0.36) NAMPTIGF1RCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed